1. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples
   Xuan Dung Ho et al, 2017, Experimental Biology and Medicine CrossRef
2. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications
   Fatemeh Sadoughi et al, 2021, DNA Repair CrossRef
3. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma
   Chao Yu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
4. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma
   Bo Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
5. Cytotoxic Tolerance of Healthy and Cancerous Bone Cells to Anti-microbial Phenolic Compounds Depend on Culture Conditions
   Ozge Karadas et al, 2019, Applied Biochemistry and Biotechnology CrossRef
6. Paget’s Disease of the Bone and Lynch Syndrome: An Exceptional Finding
   Ana-Maria Gheorghe et al, 2023, Diagnostics CrossRef
7. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis
   Bo Dong et al, 2017, Gene CrossRef
8. Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma
   Qing-hong Su et al, 2019, Chinese Journal of Integrative Medicine CrossRef
9. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma
   Gaoyang Chen et al, 2018, PLOS ONE CrossRef
10. PAIP1 is a novel oncogene in human hepatocellular carcinoma
    Nuobei Zhang et al, 2022, Discover Oncology CrossRef
11. Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
    Wei Liu et al, 2020, Molecular Oncology CrossRef